The Senate candidates in Missouri seem to find a stem cell research initiative on the ballot almost too hot to touch.

US OKs new Merck drug for rare skin cancer Reuters.uk - By Lisa Richwine. WASHINGTON (Reuters) - Merck & Co Inc. won US approval for a new drug to treat a rare and slow-growing skin cancer, health officials said on Friday.

In North America, 37 percent are obese and 5.8 percent are morbidly obese, much higher proportions than in other regions of the world.